Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan to Portfolio Company

17 Jun 2014 10:26

RNS Number : 8088J
Adamas Finance Asia Limited
17 June 2014
 



Adamas Finance Asia Limited

 

("ADAM" or the "Company")

 

Loan to Portfolio Company

 

 

The Board of Adamas Finance Asia Limited (AIM ticker: ADAM) announces that the Company has agreed to advance a loan of US$2.4 million to Changtai Jinhongbang Real Estate Development Co., Ltd ("CJRE"), a company in which ADAM holds an indirect 15% interest (the "Loan").

 

CJRE is the owner of the Tian Tong Shan Villa Project (the "TTS Project"), a substantial development project for a spa resort with ancillary residential, commercial and recreational facilities in Fujian Province, China.

 

CJRE will use the Loan to fund the continuing development of the TTS Project, where Phase One is due for completion in mid-2015, and where Starwood Hotels & Resorts Worldwide, Inc. has agreed to be the operator of the planned five-star hotel trading under the Le Méridien brand. An independent valuation by Roma Appraisals Limited at 31 December 2013 valued the 15% holding in the TTS Project at US$48 million.

 

The Loan carries a coupon of 10%, payable six monthly, and has a two year term with a potential one year extension at the option of Lead Winner Limited, a wholly owned subsidiary of ADAM which holds the investment in CJRE. The application of the Loan is restricted to the continuing development of the TTS Project.

 

Funding for the Loan is being provided to ADAM by Elypsis Solutions Limited ("Elypsis") the Company's major shareholder, by means a loan with a coupon of 9%, also payable six monthly (the "Elypsis Loan").

 

Due to the shareholding of Elypsis in ADAM, the Elypsis Loan constitutes a related party transaction under Rule 13 of the AIM Rules for Companies. The Directors of ADAM (excluding Conor MacNamara, who is not deemed to be independent of Elypsis) consider, having consulted with W H Ireland Limited, the Company's nominated adviser, that the terms of the Elypsis Loan are fair and reasonable insofar as shareholders are concerned.

 

 

Enquiries:

Adamas Finance Asia Limited

John Croft

+44 (0) 1825 830587

Nominated Adviser and Broker

W H Ireland Limited

Tim Feather

+44 (0) 113 394 6611

Public Relations Advisers

First City Public Relations (Hong Kong)

Allan Piper

+852 2854 2666

Tavistock Communications (London)

Simon Hudson

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFFARSIDLIS
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.